Company: INMB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001213900-25-073077
Chunk: 92

Company: Inmune Bio, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 2
Chunk 92
---
. 

    Date: August 7, 2025
    By:
    /s/ David Moss

    David Moss

    Principal Executive Officer

    (Principal Executive Officer)

    Date: August 7, 2025 
    By:
    /s/ Cory Ellspermann

    Cory Ellspermann

    Interim Chief Financial Officer

    (Principal Financial and Accounting Officer)

40

0001711754
false
Q2
--12-31

    0001711754

    2025-01-01
    2025-06-30

    0001711754

    2025-08-07

    0001711754

    2025-06-30

    0001711754

    2024-12-31

    0001711754
    
      us-gaap:RelatedPartyMember

    2025-06-30

    0001711754
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0001711754

    2025-04-01
    2025-06-30

    0001711754

    2024-04-01
    2024-06-30

    0001711754

    2024-01-01
    2024-06-30

    0001711754
    
      us-gaap:CommonStockMember

    2024-12-31

    0001711754
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-12-31

    0001711754
    
      us-gaap:AccumulatedOtherComprehensiveIncomeMember

    2024-12-31

    0001711754
    
      us-gaap:RetainedEarningsMember

    2024-12-31

    0001711754
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-01-01
    2025-03-31

    0001711754
    
      us-gaap:AccumulatedOtherComprehensiveIncomeMember

    2025